Optimal definition for PWI/DWI mismatch in acute ischemic stroke patients
|
|
- Kathryn Patrick
- 6 years ago
- Views:
Transcription
1 & 08 ISCBFM All rights reserved X/08 $ Brief Communication Optimal definition for PWI/DWI mismatch in acute ischemic stroke patients Wataru Kakuda 1, Maarten G Lansberg 2, Vincent N Thijs 3, Stephanie M Kemp 2, Roland Bammer 4, Lawrence R Wechsler 5, Michael E Moseley 4, Michael P Parks 4 and Gregory W Albers 2, on behalf of The DEFUSE Investigators 1 Department of Rehabilitation Medicine, Jikei University School of Medicine, Minato-ku, Tokyo, Japan; 2 Department of Neurology and Neurological Sciences, Stanford Stroke Center, Stanford University Medical Center, Palo Alto, California, USA; 3 Department of Neurology, University Hospital of Leuven, UZ Gasthuisberg, Leuven, Belgium; 4 Department of Radiology, Stanford Stroke Center, Stanford University Medical Center, Palo Alto, California, USA; 5 Department of Neurology, University of Pittsburgh Medical Center Stroke Institute, Pittsburgh, Pennsylvania, USA Although the perfusion-weighted imaging/diffusion-weighted imaging (PWI/DWI) mismatch model has been proposed to identify acute stroke patients who benefit from reperfusion therapy, the optimal definition of a mismatch is uncertain. We evaluated the odds ratio for a favorable clinical response in mismatch patients with reperfusion compared with no reperfusion for various mismatch ratio thresholds in patients enrolled in the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. A mismatch ratio of 2.6 provided the highest sensitivity (90%) and specificity (83%) for identifying patients in whom reperfusion was associated with a favorable response. Defining mismatch with a larger PWI/DWI ratio may provide greater power for detecting beneficial effects of reperfusion. ; doi:.38/sj.jcbfm ; published online 9 January 08 Keywords: mismatch; ischemic penumbra; thrombolysis; acute ischemic stroke; perfusion-weighted imaging; diffusion-weighted imaging Introduction It has been postulated that magnetic resonance imaging, specifically perfusion-weighted imaging (PWI) and diffusion-weighted imaging (DWI), can be used to select acute stroke patients who are most likely to benefit from reperfusion therapy (Albers, 1999). This has been referred to as PWI/DWI Correspondence: Dr W Kakuda, 3-19-, Nishi-shimbashi, Minato-ku, Tokyo , Japan. wkakuda@jikei.ac.jp This article reports the results of a subanalysis of the DEFUSE study. The funding for the DEFUSE study was provided by NIH grants RO1 NS and NS to principal investigator, Gregory W Albers. The tissue plasminogen activator used in the study was provided by Genentech at no charge. Some of the authors have consulting relationships with Genentech or have received honoraria for lectures sponsored by Genentech, but none have any financial relationship with Genentech in excess of $,000 per year. Vincent Thijs is supported by the Fonds voor Wetenschappelijk Onderzoek Vlaanderen and the Flanders Institute of Biotechnology. Received 6 November 07; revised 29 November 07; accepted 30 November 07; published online 9 January 08 mismatch hypothesis. The hypothesis predicts that PWI/DWI mismatch, defined as PWI lesion volume minus DWI lesion volume, provides an estimate of the ischemic penumbra and that the presence of a mismatch identifies patients who are most likely to benefit from reperfusion therapy. The results of the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study (Albers et al, 06) support the validity of the mismatch hypothesis in patients treated with tissue plasminogen activator (tpa) therapy in the 3 to 6 h time window. The DEFUSE study showed that early reperfusion is associated with a more favorable clinical response in patients with the PWI/DWI mismatch profile, whereas patients without a mismatch did not appear to benefit from reperfusion. Although the PWI/DWI mismatch concept is already being used for patient selection in clinical studies (Butcher et al, 05; Hacke et al, 05; Furlan et al, 06), the criteria used to determine the presence of PWI/DWI mismatch have varied between the studies (Darby et al, 1999; Neumann- Haefelin et al, 1999; Schellinger et al, 00; Parsons et al, 02). In many studies, mismatch has been
2 888 defined as PWI lesion volume of > 1% of DWI lesion, but this threshold was chosen arbitrarily. It is conceivable that the degree of PWI/DWI mismatch is an important factor in predicting the response to reperfusion therapy. Specifically, patients with a more extensive mismatch area may be more likely to benefit from reperfusion. The aim of our study was to determine if the criteria used to define a mismatch affect the likelihood that patients with a mismatch will benefit from early restoration of blood flow (reperfusion). Consequently, the results of this study may help to refine and optimize PWI/DWI mismatch selection criteria for future acute stroke studies. Materials and methods This is a substudy of the DEFUSE study. Methods and main results of the study have been reported (Albers et al, 06). In this substudy, we included the patients who had a baseline PWI lesion X ml and technically adequate PWI and DWI data at both baseline and the 3 to 6 h followup scan. We looked for an association between the mismatch ratio and the presence of a favorable clinical response using logistic regression analysis. Subsequently, we investigated the association between and a favorable clinical response. We then assessed whether there was an interaction between, mismatch ratio, and favorable clinical response using logistic regression (Jaccard, 01). Diffusionweighted imaging was performed using a spin echo echo-planar imaging sequence (field of view = 240 mm, repetition time = 5 secs, echo time = minimum allowed, slice thickness = 5 mm, number of slices = 19, slice gap = 1 mm, acquisition matrix ) and lesion volumes determined using a semiautomated thresholding algorithm, which identified regions of high signal intensity that exceeded a region in the contralateral frontal lobe by more than 3 s.d. Dynamic susceptibility PWI was performed using gradient echo echo-planar imaging (field of view = 240 mm, repetition time = 2 secs, echo time = 60 ms, slice thickness = 7 mm, number of slices = 12, slice gap = 0, acquisition matrix , dynamic scans = 40) and time to peak of the residue function (T max ) maps were generated by deconvolution of the tissue concentration over time curve using an arterial input function from the contralateral middle cerebral artery. A 2-sec delay was used as the lower threshold indicating ischemic or hypoperfused tissue. Early reperfusion was defined as a X30% and X ml reduction in PWI lesion volume on the 3 to 6 h follow-up scan compared with the baseline (pretreatment scan). A favorable clinical response was defined as National Institutes of Health Stroke Scale score of 0 to 1 or X8 point improvement at 30 days. Odds ratios for favorable clinical response for patients with PWI/DWI mismatch and were calculated for multiple possible PWI/DWI mismatch definitions. The optimal mismatch ratio for predicting a favorable clinical response in patients with early reperfusion was determined using receiver operating characteristic analysis between mismatch ratio and favorable clinical response. All statistical analyses were performed using SPSS statistical software (Chicago, IL, USA). Results Forty-five patients met the inclusion criteria for this substudy. There were no significant differences between patients who did or did not have early reperfusion in baseline characteristics, except for age ( patients were older). There were no significant differences between patients with and without favorable clinical response (Table 1). The rate of in this cohort was 49% (22 of 45 patients). There was no significant relationship between mismatch ratio and the probability of reperfusion (P = with Wilcoxon rank sum test). Neither mismatch ratio (OR: 0.99, 95% CI: 0.8 to 1.2, P = 0.87), nor reperfusion (OR: 1.6, 95% CI: 0.5 to 5.2, P = 0.47) was associated with favorable clinical response. However, the interaction term mismatch ratio times reperfusion was significantly associated with favorable clinical response (P for interaction = ). In the presence of reperfusion, as shown in Figure 1, increasing mismatch ratio was associated with a higher response rate (OR: 1.7, 95% CI: 1.1 to 2.5). In the absence of reperfusion, increasing mismatch ratio was associated with a lower frequency of good clinical response (OR: 0.6, 95% CI: 0.3 to 0.9). Receiver operating characteristic analysis shows that a mismatch ratio of 2.6 gives the highest sensitivity (90%) and specificity (83%) for predicting a favorable clinical response in patients who achieve (odds ratio 31.5, 95% CI 3.7 to 265.4). When the PWI/DWI ratio cutoff used to define mismatch was increased, the odds ratio for a favorable outcome in mismatch patients with early reperfusion versus mismatch patients without early reperfusion increased (R 2 = 0.791; P = 0.001). The number of patients with a mismatch gradually decreased from 84% (38 patients) with a mismatch ratio definition of X1.2 to 51% (23 patients) with a ratio of X4 (Figure 1). Discussion The DEFUSE data show that for acute stroke patients with PWI/DWI mismatch, the favorable clinical response rate associated with is related to the degree of mismatch. There is a lack of consensus regarding the definition of PWI/DWI mismatch. For the DEFUSE study, the prespecified ratio chosen to define PWI/DWI mismatch was 1.2, and a minimum mismatch volume of ml was required. Although a ratio of > 1.2 has been widely used in stroke trials (Butcher et al, 05; Hacke et al, 05;
3 Table 1 Comparisons of baseline characteristics 889 Factors Between patients with and without Between patients with and without favorable clinical response Patients with (n = 22) Patients without (n = 23) P-value Patients with favorable clinical response (n = ) Patients without favorable clinical response (n = 27) P-value Age, mean (s.d.) 78.5 (8.4) 66.5 (.3) (17.1) 73.5 (14.4) 0.55 White (%) Female (%) Baseline NIHSS, 14 (9 ) 13 (9 ) ( ) 13 (9 ) 0.89 median (IQR) Hypertension (%) Cardiac disease (%) Diabetes mellitus (%) Cigarette smoking (current and previous) (%) Hyperlipidemia (%) Prior stroke/tia (%) DWI lesion volume 19 (8 45) 11 (5 26) (7 45) (5 30) 0.89 baseline, median (IQR) (ml) PWI lesion volume baseline, median (IQR) (ml) 75 (44 127) 66 (34 2) (49 97) 65 (34 5) 0.25 NIHSS, National Institutes of Health Stroke Scale; IQR, interquartile range. Comparisons between two groups were performed with Student s t-test (age), w 2 -test (dichotomous variables), and Wilcoxon rank sum test (NIHSS, DWI lesion, PWI lesion). Frequency of Favorable Clinical Response (%) R(+) R(-) With Early Reperfusion Without Early Reperfusion All patients Mismatch Ratio * R (+): No.of patients with, R (-): No.of patients without Figure 1 The frequency of favorable clinical response in patients with increases with increasing mismatch ratio. In contrast, larger mismatch ratios are associated with a decrease in favorable outcome for patients who did not have reperfusion. The overall rates of (approximately 50%) and favorable clinical response (about 40%) did not change significantly based on mismatch ratio. Four patients had mismatch ratios of < 1 and are not included in the figure. *R ( + ): number of patients with, R ( ): number of patients without Furlan et al, 06) as well as nonrandomized stroke studies (Schellinger et al, 00; Parsons et al, 02), others have defined PWI DWI mismatch as a ratio >1.0(Darby et al, 1999; Neumann-Haefelin et al, 1999). To our knowledge, no previous study has attempted to determine the optimal definition for mismatch. Our data suggest that a more stringent definition of mismatch, requiring a greater mismatch ratio, has the potential to identify patients who have a particularly robust clinical response to early reperfusion. These findings are consistent with the concept that the mismatch provides an estimate of the ischemic penumbra; patients estimated to have a large volume of penumbral tissue are most likely to benefit from reperfusion and most likely to have poor outcomes if reperfusion is not achieved. The lower favorable clinical response rate in patients with reperfusion and small mismatch ratio has several possible explanations. It is likely that penumbral tissue is being recruited into the
4 890 ischemic core during the delay between the baseline magnetic resonance imaging and the occurrence of reperfusion. This delay includes the magnetic resonance imaging-to-needle time and the time from initiation of therapy to actual reperfusion. As a result, for patients with small mismatch ratios, little salvageable tissue may remain by the time reperfusion occurs. In addition, mismatch areas determined by PWI and DWI likely include regions of benign oligemia that will survive regardless of reperfusion, as well as critically hypoperfused areas at high risk of infarction (Kidwell et al, 1999). With smaller mismatch ratios, mismatch areas may primarily contain regions of benign oligemia. A more stringent definition of PWI/DWI mismatch reduces the number of patients designated as having a mismatch. This would decrease the number of patients who are considered to be eligible for a trial of a reperfusion therapy if mismatch is used as an inclusion criterion for study entry. For example, requiring a mismatch ratio of X2.6 would have excluded 25% of the mismatch patients in DEFUSE. In retrospect, a more desirable choice might have been requiring a ratio of X1.8 because only about % of the patients would have been excluded; yet the odds ratio for achieving a favorable clinical response after would have more than doubled. While requiring a larger mismatch ratio would reduce the number of patients who are eligible for inclusion in a randomized trial of a reperfusion therapy, the anticipated improvement in the clinical response rate among patients with reperfusion (and low rate of favorable response in non-reperfusion patients) would reduce the total sample size estimate for the trial. This approach will require an automated PWI processing program that can rapidly identify the mismatch ratio. Several groups have developed programs that can accomplish this, but these tools have not yet been incorporated into the software packages offered by magnetic imaging imaging manufactures. This study has some limitations; most importantly, the sample size was small and confirmation of these findings in a large data set is required. In addition, mismatch ratio varies based on the techniques used to analyze PWI data. In DEFUSE, perfusion maps were constructed using T max with a 2-sec delay as the lower threshold indicating hypoperfused brain tissue. Other T max thresholds or other PWI analysis techniques may yield different estimates of the optimal mismatch ratio. T max is the maximum of the tissue residue function characteristic to each voxel and reflects how much the tissue response lags behind the stimulus by an arterial input into the voxel. If the perfusion pressure decreases, the influx into a voxel after an arterial input stimulus is delayed and hence T max will increase. T max can be viewed as the bolus arrival time corrected for the confounding effects of bolus administration (e.g., injection rate and flow, cardiac output). While T max does not measure tissue microperfusion directly, studies (Shih et al, 03; Thijs et al, 04) have shown that T max is a sensitive surrogate marker that detects perfusion deficits and tissue that is likely destined for infarction if reperfusion does not occur. It is possible that imbalances in baseline predictors of favorable outcome could confound our results. We believe that this is unlikely, as key baseline predictors of clinical outcomes did not differ between patients with high versus low mismatch ratios. In addition, a multivariate analysis that corrected for baseline imbalances in age, baseline National Institutes of Health Stroke Scale, time to treatment, PWI volume, and glucose was performed as part of the primary analysis of the DEFUSE results. The odds ratio for the association between reperfusion and favorable outcome in mismatch patients increased from 5.4 (95% CI, 1.1 to 25.8, P = 0.039) to 7.7 (95% CI, 1.3 to 44.8, P = 0.022) after correction for baseline imbalances. A placebo-controlled trial is required to determine if tpa is an effective therapy beyond 3 h. If tpa is more effective than placebo for some patient subgroups beyond 3 h, our data argue that a larger mismatch ratio may identify tpa responders because large mismatch ratios are associated with a very high rate of good outcome if reperfusion occurs and a very low rate if reperfusion does not occur. However, it is uncertain whether tpa is associated with a higher reperfusion rate than placebo in patients with large mismatch ratios and whether the adverse effects of tpa differ based on mismatch ratio. In conclusion, use of larger PWI/DWI mismatch ratios than have typically been chosen to define mismatch may provide greater power for detecting beneficial clinical effects of reperfusion in future clinical trials. References Albers GW (1999) Expanding the window for thrombolytic therapy in acute stroke. The potential role of acute MRI for patient selection. Stroke 30: Albers GW, Thijs VN, Wechsler L, Kemp S, Schlaug G, Skalabrin E, Bammer R, Kakuda W, Lansberg MG, Shuaib A, Coplin W, Hamilton S, Moseley M, Marks MP, DEFUSE Investigators (06) Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DE- FUSE) study. Ann Neurol 60: Butcher KS, Parsons M, MacGregor L, Barber PA, Chalk J, Bladin C, Levi C, Kimber T, Schultz D, Fink J, Tress B, Donnan G, Davis S, EPITHET Investigators (05) Refining the perfusion diffusion mismatch hypothesis. Stroke 36:13 9 Darby DG, Barber PA, Gerraty RP, Desmond PM, Yang Q, Parsons M, Li T, Tress BM, Davis SM (1999) Pathophysiological topography of acute ischemia by combined diffusion-weighted and perfusion MRI. Stroke 30:43 52
5 Furlan AJ, Eyding D, Albers GW, Al-Rami Y, Lees KR, Rowley HA, Sachara C, Soehngen M, Warach S, Hacke W, DEDAS Investigators (06) Dose escalation of desmoteplase for acute ischemic stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 37: Hacke W, Albers G, Al-Rawi Y, Bogousslavsky J, Davalos A, Eliasziw M, Fisher M, Furlan A, Kaste M, Lees KR, Soehngen M, Warach S, DIAS Study Group (05) The desmoteplase in acute ischemic stroke trial (DIAS): a phase 2 MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 36:66 73 Jaccard J (01) Interaction effects in logistic regression: Sage University papers on quantitative applications in the social sciences. Thousand Oaks, CA: Sage Kidwell CS, Alger JR, Saver JL (1999) Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke 34: Neumann-Haefelin T, Wittsack HJ, Wenserski F, Siebler M, Seitz RJ, Modder U, Freund HJ (1999) Diffusion- and perfusion-weighted MRI. The DWI/PWI mismatch region in acute stroke. Stroke 30:91 7 Parsons MW, Barber PA, Chalk J, Darby DG, Rose S, Desmond PM, Gerraty RP, Tress BM, Wright PM, Donnan GA, Davis SM (02) Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke. Ann Neurol 51:28 37 Schellinger PD, Jansen O, Fiebach JB, Heiland S, Steiner T, Schwab S, Pohlers O, Ryssel H, Sartor K, Hacke W (00) Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI. Stroke 31:13 28 Shih LC, Saver JL, Alger JR, Starkman S, Leary MC, Vinuela F, Duckwiler G, Gobin YP, Jahan R, Villablanca JP, Vespa PM, Kidwell CS (03) Perfusion-weighted magnetic resonance imaging thresholds identifying core, irreversibly infarcted tissue. Stroke 34: Thijs VN, Somford DM, Bammer R, Robberecht W, Moseley ME, Albers GW (04) Influence of arterial input function on hypoperfusion volumes measured with perfusion-weighted imaging. Stroke 35:
Comparison of Magnetic Resonance Imaging Mismatch Criteria to Select Patients for Endovascular Stroke Therapy
Comparison of Magnetic Resonance Imaging Mismatch Criteria to Select Patients for Endovascular Stroke Therapy Nishant K. Mishra, MBBS, PhD, FESO; Gregory W. Albers, MD; Søren Christensen, PhD; Michael
More informationA Topographic Study of the Evolution of the MR DWI/PWI Mismatch Pattern and Its Clinical Impact A Study by the EPITHET and DEFUSE Investigators
A Topographic Study of the Evolution of the MR DWI/PWI Mismatch Pattern and Its Clinical Impact A Study by the EPITHET and DEFUSE Investigators Toshiyasu Ogata, MD; Yoshinari Nagakane, MD; Soren Christensen,
More informationEffect of Collateral Blood Flow on Patients Undergoing Endovascular Therapy for Acute Ischemic Stroke
Effect of Collateral Blood Flow on Patients Undergoing Endovascular Therapy for Acute Ischemic Stroke Michael P. Marks, MD; Maarten G. Lansberg, MD; Michael Mlynash, MD; Jean-Marc Olivot, MD; Matus Straka,
More informationThe Declaration of Helsinki 1 stipulates that patients who
Brain Lesion Volume and Capacity for Consent in Stroke Trials Potential Regulatory Barriers to the Use of Surrogate Markers Krishna A. Dani, MRCP; Michael T. McCormick, MRCP; Keith W. Muir, MD, FRCP Background
More informationDynamic susceptibility contract-enhanced MRI is increasingly
Influence of Arterial Input Function on Hypoperfusion Volumes Measured With Perfusion-Weighted Imaging Vincent N. Thijs, MD; Diederik M. Somford, MD; Roland Bammer, PhD; Wim Robberecht, MD, PhD; Michael
More informationImmediate Changes in Stroke Lesion Volumes Post Thrombolysis Predict Clinical Outcome
Immediate Changes in Stroke Lesion Volumes Post Thrombolysis Predict Clinical Outcome Marie Luby, PhD; Steven J. Warach, MD, PhD; Zurab Nadareishvili, MD, PhD; José G. Merino, MD, MPhil Background and
More informationRapid Assessment of Perfusion Diffusion Mismatch
Rapid Assessment of Perfusion Diffusion Mismatch Ken Butcher, MD, PhD; Mark Parsons, PhD, FRACP; Louise Allport, FRACP; Sang Bong Lee, PhD; P. Alan Barber, PhD, ZRACP; Brian Tress, FRACR; Geoffrey A. Donnan,
More informationHypoperfusion Intensity Ratio Predicts Infarct Progression and Functional Outcome in the DEFUSE 2 Cohort
Hypoperfusion Intensity Ratio Predicts Infarct Progression and Functional Outcome in the DEFUSE 2 Cohort Jean Marc Olivot, MD, PhD; Michael Mlynash, MD, MS; Manabu Inoue, MD, PhD; Michael P. Marks, MD;
More informationMRI Screening Before Standard Tissue Plasminogen Activator Therapy Is Feasible and Safe
MRI Screening Before Standard Tissue Plasminogen Activator Therapy Is Feasible and Safe Dong-Wha Kang, MD, PhD; Julio A. Chalela, MD; William Dunn, MD; Steven Warach, MD, PhD; NIH-Suburban Stroke Center
More informationClinical-Diffusion Mismatch Predicts the Putative Penumbra With High Specificity
Clinical-Diffusion Mismatch Predicts the Putative Penumbra With High Specificity Jane Prosser, FRACP; Ken Butcher, MD, PhD, FRCP(C); Louise Allport, FRACP; Mark Parsons, PhD, FRACP; Lachlan MacGregor,
More informationEPITHET Positive Result After Reanalysis Using Baseline Diffusion-Weighted Imaging/Perfusion-Weighted Imaging Co-Registration
EPITHET Positive Result After Reanalysis Using Baseline Diffusion-Weighted Imaging/Perfusion-Weighted Imaging Co-Registration Yoshinari Nagakane, MD, PhD; Soren Christensen, PhD; Caspar Brekenfeld, MD;
More informationReperfusion of the ischemic penumbra (ie, at-risk but
Refinement of the Magnetic Resonance Diffusion-Perfusion Mismatch Concept for Thrombolytic Patient Selection Insights From the Desmoteplase in Acute Stroke Trials Steven Warach, MD, PhD; Yasir Al-Rawi,
More informationSubject: Anthem Policy Mechanical Embolectomy for Treatment of Acute Stroke
John Whitney, MD Office of Medical Policy, Technology, Assessment and Credentialing WellPoint, Inc. 233 South Wacker Dr., Ste 3900 Chicago, IL 60606 (518) 367-5422 John.whitney@wellpoint.com Subject: Anthem
More informationTreatment with intravenous tissue plasminogen activator
RAPID Automated Patient Selection for Reperfusion Therapy A Pooled Analysis of the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) and the Diffusion and Perfusion Imaging Evaluation for Understanding
More informationThe role of diffusion and perfusion MRI for the identification
The Physiological Significance of the Time-to-Maximum (Tmax) Parameter in Perfusion MRI Fernando Calamante, PhD; Søren Christensen, PhD; Patricia M. Desmond, MD, FRANZCR; Leif Østergaard, MD, PhD; Stephen
More informationThrombolysis is the only proven pharmacological treatment
Perfusion Thresholds in Acute Stroke Thrombolysis K. Butcher, MD, PhD, FRCP(C); M. Parsons, PhD, FRACP; T. Baird, MBBS; A. Barber, PhD, FRANZ; G. Donnan, MD, FRACP; P. Desmond, FRACR; B. Tress, FRACR;
More informationDong Gyu Na, Vincent N. Thijs, Gregory W. Albers, Michael E. Moseley, and Michael P. Marks. AJNR Am J Neuroradiol 25: , September 2004
AJNR Am J Neuroradiol 25:1331 1336, September 2004 Diffusion-Weighted MR Imaging in Acute Ischemia: Value of Apparent Diffusion Coefficient and Signal Intensity Thresholds in Predicting Tissue at Risk
More informationThe association between neurological deficit in acute ischemic stroke and mean transit time
Neuroradiology (2006) 48: 69 77 DOI 10.1007/s00234-005-0012-9 DIAGNOSTIC NEURORADIOLOGY Peter D. Schellinger Lawrence L. Latour Chen-Sen Wu Julio A. Chalela Steven Warach The association between neurological
More informationAnalysis of DWI ASPECTS and Recanalization Outcomes of Patients with Acute-phase Cerebral Infarction
J Med Dent Sci 2012; 59: 57-63 Original Article Analysis of DWI ASPECTS and Recanalization Outcomes of Patients with Acute-phase Cerebral Infarction Keigo Shigeta 1,2), Kikuo Ohno 1), Yoshio Takasato 2),
More informationBenign Oligemia Despite a Malignant MRI Profile in Acute Ischemic Stroke
CASE REPORT J Clin Neurol 2010;6:41-45 Print ISSN 1738-6586 / On-line ISSN 2005-5013 10.3988/jcn.2010.6.1.41 Benign Oligemia Despite a Malignant MRI Profile in Acute Ischemic Stroke Oh Young Bang, MD a
More informationStroke is the leading cause of serious, long-term disability
Cost-Effectiveness of Patient Selection Using Penumbral-Based MRI for Intravenous Thrombolysis Stephanie R. Earnshaw, PhD; Dan Jackson, MSc; Ray Farkouh, PhD; Lee Schwamm, MD Background and Purpose Better
More informationRemission of diffusion lesions in acute stroke magnetic resonance imaging
ORIGINAL RESEARCH Remission of diffusion lesions in acute stroke magnetic resonance imaging F. A. Fellner 1, M. R. Vosko 2, C. M. Fellner 1, D. Flöry 1 1. AKH Linz, Institute of Radiology, Austria. 2.
More informationReview Use of diffusion and perfusion magnetic resonance imaging as a tool in acute stroke clinical trials Steven Warach
Review Use of diffusion and perfusion magnetic resonance imaging as a tool in acute stroke clinical trials Steven Warach Section on Stroke Diagnostics and Therapeutics, National Institute of Neurological
More informationThe clinical DWI mismatch
The clinical DWI mismatch A new diagnostic approach to the brain tissue at risk of infarction A. Dávalos, MD, PhD; M. Blanco, MD, PhD; S. Pedraza, MD; R. Leira, MD, PhD; M. Castellanos, MD; J.M. Pumar,
More informationImpact of Slow Blood Filling via Collaterals on Infarct Growth: Comparison of Mismatch and Collateral Status
Journal of Stroke 2017;19(1):88-96 Original Article Impact of Slow Blood Filling via Collaterals on Infarct Growth: Comparison of Mismatch and Collateral Status Jeong Pyo Son, a,b Mi Ji Lee, c Suk Jae
More informationPerfusion-weighted imaging (PWI) and diffusionweighted
Apparent Diffusion Coefficient Thresholds Do Not Predict the Response to Acute Stroke Thrombolysis Poh-Sien Loh, FRACP; Ken S. Butcher, MD, PhD, FRCP(C), FRACP; Mark W. Parsons, PhD, FRACP; Lachlan MacGregor,
More informationNeuroimaging for acute ischemic stroke: current challenges
Zurich Open Repository and Archive University of Zurich Main Library Strickhofstrasse 39 CH-8057 Zurich www.zora.uzh.ch Year: 2014 Neuroimaging for acute ischemic stroke: current challenges Wegener, Susanne
More informationThe only US Food and Drug Administration-approved
Quantitative Assessment of Core/Penumbra Mismatch in Acute Stroke CT and MR Perfusion Imaging Are Strongly Correlated When Sufficient Brain Volume Is Imaged Pamela W. Schaefer, MD; Elizabeth R. Barak,
More informationBackground. Recommendations for Imaging of Acute Ischemic Stroke: A Scientific Statement From the American Heart Association
for Imaging of Acute Ischemic Stroke: A Scientific Statement From the American Heart Association An Scientific Statement from the Stroke Council, American Heart Association and American Stroke Association
More informationBY MARILYN M. RYMER, MD
Lytics, Devices, and Advanced Imaging The evolving art and science of acute stroke intervention. BY MARILYN M. RYMER, MD In 1996, when the US Food and Drug Administration (FDA) approved the use of intravenous
More informationPerfusion-Weighted Magnetic Resonance Imaging Thresholds Identifying Core, Irreversibly Infarcted Tissue
Perfusion-Weighted Magnetic Resonance Imaging Thresholds Identifying Core, Irreversibly Infarcted Tissue Ludy C. Shih, MD; Jeffrey L. Saver, MD; Jeffry R. Alger, PhD; Sidney Starkman, MD; Megan C. Leary,
More informationReperfusion therapy improves outcomes of patients with acute
Published September 25, 2014 as 10.3174/ajnr.A4103 ORIGINAL RESEARCH BRAIN Combining MRI with NIHSS Thresholds to Predict Outcome in Acute Ischemic Stroke: Value for Patient Selection P.W. Schaefer, B.
More informationClinical Sciences. Arterial Spin Labeling Versus Bolus-Tracking Perfusion in Hyperacute Stroke
Clinical Sciences Arterial Spin Labeling Versus Bolus-Tracking Perfusion in Hyperacute Stroke Andrew Bivard, PhD; Venkatesh Krishnamurthy, MRCP, FRACP; Peter Stanwell, PhD; Christopher Levi, MBBS, FRACP;
More informationProgress Review. Magnetic Resonance Imaging Criteria for Thrombolysis in Acute Cerebral Infarct
Progress Review Magnetic Resonance Imaging Criteria for Thrombolysis in Acute Cerebral Infarct N. Hjort, MD; K. Butcher, MD, PhD, FRCP(C); S.M. Davis, MD, FRACP; C.S. Kidwell, MD; on behalf of the UCLA
More informationMR and CT Perfusion in Acute Ischemic Stroke The uses, methods, and risks associated with these alternative imaging modalities.
MR and CT Perfusion in Acute Ischemic Stroke The uses, methods, and risks associated with these alternative imaging modalities. BY CATALINA C. IONITA, MD; EVE A. GUTERMAN; AND LEE R. GUTERMAN, PHD, MD
More informationThe Value of Arterial Spin-Labeled Perfusion Imaging in Acute Ischemic Stroke Comparison With Dynamic Susceptibility Contrast-Enhanced MRI
The Value of Arterial Spin-Labeled Perfusion Imaging in Acute Ischemic Stroke Comparison With Dynamic Susceptibility Contrast-Enhanced MRI Danny J.J. Wang, PhD, MSCE; Jeffry R. Alger, PhD; Joe X. Qiao,
More informationTmax Determined Using a Bayesian Estimation Deconvolution Algorithm Applied to Bolus Tracking Perfusion Imaging: A Digital Phantom Validation Study
Magn Reson Med Sci 2017; 16; 32 37 doi:10.2463/mrms.mp.2015-0167 Published Online: March 21, 2016 MAJOR PAPER Tmax Determined Using a Bayesian Estimation Deconvolution Algorithm Applied to Bolus Tracking
More informationA Trial of Imaging Selection and Endovascular Treatment for Ischemic Stroke
T h e n e w e ngl a nd j o u r na l o f m e dic i n e original article A Trial of Imaging Selection and Endovascular Treatment for Ischemic Stroke Chelsea S. Kidwell, M.D., Reza Jahan, M.D., Jeffrey Gornbein,
More informationComparison of 10 Perfusion MRI Parameters in 97 Sub-6-Hour Stroke Patients Using Voxel-Based Receiver Operating Characteristics Analysis
Comparison of 10 Perfusion MRI Parameters in 97 Sub-6-Hour Stroke Patients Using Voxel-Based Receiver Operating Characteristics Analysis Søren Christensen, MSc; Kim Mouridsen, PhD; Ona Wu, PhD; Niels Hjort,
More informationDiffusion-Weighted Imaging Results in Higher Accuracy and Lower Interrater Variability in the Diagnosis of Hyperacute Ischemic Stroke
CT and Diffusion-Weighted MR Imaging in Randomized Order Diffusion-Weighted Imaging Results in Higher Accuracy and Lower Interrater Variability in the Diagnosis of Hyperacute Ischemic Stroke J.B. Fiebach,
More informationMultiparametric MRI and CT Models of Infarct Core and Favorable Penumbral Imaging Patterns in Acute Ischemic Stroke
Multiparametric MRI and CT Models of Infarct Core and Favorable Penumbral Imaging Patterns in Acute Ischemic Stroke Chelsea S. Kidwell, MD; Max Wintermark, MD; Deidre A. De Silva, MD; Timothy J. Schaewe,
More informationOver the past 2 decades, advanced multimodal imaging has
February 2013 Basic Science Advances for Clinicians Section Editors: Anna M. Planas, PhD, and Richard J. Traystman, PhD MRI Biomarkers in Acute Ischemic Stroke: A Conceptual Framework and Historical Analysis
More informationTitle: Stability of Large Diffusion/Perfusion Mismatch in Anterior Circulation Strokes for 4 or More Hours
Author's response to reviews Title: Stability of Large Diffusion/Perfusion Mismatch in Anterior Circulation Strokes for 4 or More Hours Authors: Ramon G. Gonzalez (rggonzalez@partners.org) Reza Hakimelahi
More informationBiomedical Research 2017; 28 (17):
Biomedical Research 2017; 28 (17): 7578-7582 ISSN 0970-938X www.biomedres.info Fusion images of perfusion- and diffusion-weighted MR imaging: A simple diagnostic approach of ischemic penumbra selection
More informationIntravenous thrombolysis with recombinant tissue plasminogen
ORIGINAL RESEARCH BRAIN Susceptibility-Diffusion Mismatch Predicts Thrombolytic Outcomes: A Retrospective Cohort Study M. Lou, Z. Chen, J. Wan, H. Hu, X. Cai, Z. Shi, and J. Sun ABSTRACT BACKGROUND AND
More informationThis study is the culmination of work performed in response
ORIGINAL RESEARCH J.M. Provenzale K. Shah U. Patel D.C. McCrory Systematic Review of CT and MR Perfusion Imaging for Assessment of Acute Cerebrovascular Disease BACKGROUND AND PURPOSE: Perfusion imaging
More informationEarly identification of tissue at risk of infarction after
Predicting Tissue Outcome From Acute Stroke Magnetic Resonance Imaging Improving Model Performance by Optimal Sampling of Training Data Kristjana Yr Jonsdottir, PhD, MSc; Leif Østergaard, DMSc, PhD, MD,
More informationACUTE STROKE IMAGING
ACUTE STROKE IMAGING Mahesh V. Jayaraman M.D. Director, Inter ventional Neuroradiology Associate Professor Depar tments of Diagnostic Imaging and Neurosurger y Alper t Medical School at Brown University
More informationCT/MRI 第 42 回日本脳卒中学会講演シンポジウム 総説 はじめに. MRI magnetic resonance imaging DWI diffusion-weighted. DWI/CBF malignant profile
第 42 回日本脳卒中学会講演シンポジウム 総説 CT/MRI 1 要旨 rt-pa MRI magnetic resonance imaging DWI diffusion-weighted image Tmax time-to-maximum DWI/PWI perfusion image mismatch CT computed tomography CBF cerebral blood flow
More informationSTATE OF THE ART IMAGING OF ACUTE STROKE
STATE OF THE ART IMAGING OF ACUTE STROKE Marin Penkov UH St Ivan Rilski Sofia RadiologyTogether 2-3 June 2017 GOALS The concept and significance of penumbra CT and MRI Basic Principles Clinical application
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/44385 holds various files of this Leiden University dissertation. Author: Ayata, C. Title: Spreading depolarizations : the missing link between mirgraine
More informationEpidemiology. Epidemiology 6/1/2015. Cerebral Ischemia
Presenter Disclosure Information Paul Nyquist MD/MPH FCCM FAHA Updates on the Acute Care of Ischemic Stroke and Intracranial Hemorrhage Updates on the Acute Care of Ischemic Stroke Paul Nyquist MD/MPH,
More informationORIGINAL CONTRIBUTION
ORIGINAL CONTRIBUTION Relationship Between Magnetic Resonance Arterial Patency and Perfusion-Diffusion in Acute Ischemic Stroke and Its Potential Clinical Use Irina A. Staroselskaya, MD; Claudia Chaves,
More informationAdvanced imaging in acute stroke management-part II: Magnetic resonance imaging
Review Article Advanced imaging in acute stroke management-part II: Magnetic resonance imaging Monica Saini, Ken Butcher Department of Medicine, Stroke Unit, Division of Neurology, University of Alberta,
More informationAssociation of Early CT Abnormalities, Infarct Size, and Apparent Diffusion Coefficient Reduction in Acute Ischemic Stroke
AJNR Am J Neuroradiol 25:933 938, June/July 2004 Association of Early CT Abnormalities, Infarct Size, and Apparent Diffusion Coefficient Reduction in Acute Ischemic Stroke Diederik M. Somford, Michael
More informationThe Value of Apparent Diffusion Coefficient Maps in Early Cerebral Ischemia
AJNR Am J Neuroradiol 22:1260 1267, August 2001 The Value of Apparent Diffusion Coefficient Maps in Early Cerebral Ischemia Patricia M. Desmond, Amanda C. Lovell, Andrew A. Rawlinson, Mark W. Parsons,
More informationPredicting Final Infarct Size Using Acute and Subacute Multiparametric MRI Measurements in Patients With Ischemic Stroke
JOURNAL OF MAGNETIC RESONANCE IMAGING 21:495 502 (2005) Original Research Predicting Final Infarct Size Using Acute and Subacute Multiparametric MRI Measurements in Patients With Ischemic Stroke Mei Lu,
More informationClinical profile of patients with acute ischemic stroke receiving intravenous thrombolysis (rtpa-alteplase)
International Journal of Advances in Medicine Jagini SP et al. Int J Adv Med. 2018 Feb;5(1):164-169 http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20180078
More informationSuccessful outcome after endovascular thrombolysis for acute ischemic stroke with basis on perfusion-diffusion mismatch after 24 h of symptoms onset
SNI: Cerebrovascular, a supplement to Surgical Neurology International OPEN ACCESS For entire Editorial Board visit : http://www.surgicalneurologyint.com Editor: James I. Ausman, MD, PhD University of
More informationRedgrave JN, Coutts SB, Schulz UG et al. Systematic review of associations between the presence of acute ischemic lesions on
6. Imaging in TIA 6.1 What type of brain imaging should be used in suspected TIA? 6.2 Which patients with suspected TIA should be referred for urgent brain imaging? Evidence Tables IMAG1: After TIA/minor
More informationOBJECTIVES: INTRODUCTION ADVANCES IN ACUTE STROKE CARE
Brian A. Stettler, MD Assistant Professor, Department of Emergency Medicine, University of Cincinnati College of Medicine Member, Greater Cincinnati/Northern Kentucky Stroke Team Cincinnati, Ohio OBJECTIVES:
More informationWAKE-UP has received funding from the European Union Seventh Framework Programme (FP7/ ) under grant agreement n
Intravenous Thrombombolysis in Stroke Patients with Unknown Time of Onset Results of the Multicentre, Randomized, Double-blind, Placebo- Controlled WAKE-UP Trial G. Thomalla, C.Z. Simonsen, F. Boutitie,
More informationDownloaded from by on October 4, 2018
Regional Very Low Cerebral Blood Volume Predicts Hemorrhagic Transformation Better Than Diffusion-Weighted Imaging Volume and Thresholded Apparent Diffusion Coefficient in Acute Ischemic Stroke Bruce C.V.
More informationBroadening the Stroke Window in Light of the DAWN Trial
Broadening the Stroke Window in Light of the DAWN Trial South Jersey Neurovascular and Stroke Symposium April 26, 2018 Rohan Chitale, MD Assistant Professor of Neurological Surgery Vanderbilt University
More informationA retrospective study on intracerebral haemorrhage reduction by MRI versus CT in intravenous thrombolysis for acute ischaemic stroke
Hong Kong Journal of Emergency Medicine A retrospective study on intracerebral haemorrhage reduction by MRI versus CT in intravenous thrombolysis for acute ischaemic stroke YH Yun, JY Chung, MJ Kang, JT
More informationRESEARCH ARTICLE. Computed Tomographic Perfusion to Predict Response to Recanalization in Ischemic Stroke
RESEARCH ARTICLE Computed Tomographic Perfusion to Predict Response to Recanalization in Ischemic Stroke Maarten G. Lansberg, MD, PhD, 1 Soren Christensen, PhD, 1 Stephanie Kemp, 1 Michael Mlynash, MD,
More informationTissue plasminogen activator (tpa) is the only approved
Safety and Efficacy of Intravenous Tissue Plasminogen Activator Stroke Treatment in the 3- to 6-Hour Window Using Multimodal Transcranial Doppler/MRI Selection Protocol Marc Ribo, MD, PhD; Carlos A. Molina,
More informationframework for flow Objectives Acute Stroke Treatment Collaterals in Acute Ischemic Stroke framework & basis for flow
Acute Stroke Treatment Collaterals in Acute Ischemic Stroke Objectives role of collaterals in acute ischemic stroke collateral therapeutic strategies David S Liebeskind, MD Professor of Neurology & Director
More informationIntravenous thrombolysis with intravenous tissue plasminogen
Outcome and Symptomatic Bleeding Complications of Intravenous Thrombolysis Within 6 Hours in MRI-Selected Stroke Patients Comparison of a German Multicenter Study With the Pooled Data of ATLANTIS, ECASS,
More informationThe National Institutes of Health Stroke Scale (NIHSS)
Is the Association of National Institutes of Health Stroke Scale Scores and Acute Magnetic Resonance Imaging Stroke Volume Equal for Patients With Right- and Left-Hemisphere Ischemic Stroke? John N. Fink,
More informationPositron emission tomography (PET) provides detailed
Does the Mismatch Match the Penumbra? Magnetic Resonance Imaging and Positron Emission Tomography in Early Ischemic Stroke Jan Sobesky, MD; Olivier Zaro Weber, MD; Fritz-Georg Lehnhardt, MD; Volker Hesselmann,
More informationExploiting the full width of the therapeutic window to salvage the ischemic penumbra: imaging for cost-effective, personalized therapy
Editorial Exploiting the full width of the therapeutic window to salvage the ischemic penumbra: imaging for cost-effective, personalized therapy Stefano Bastianello a, Angelo Del Sole b, Daniele Bosone
More informationAdvanced Neuroimaging for Acute Stroke
Advanced Neuroimaging for Acute Stroke E. Bradshaw Bunney, MD, FACEP Professor Department Of Emergency Medicine University of Illinois at Chicago Swedish American Belvidere Hospital Disclosures FERNE Board
More informationValidating a Predictive Model of Acute Advanced Imaging Biomarkers in Ischemic Stroke
Validating a Predictive Model of Acute Advanced Imaging Biomarkers in Ischemic Stroke Andrew Bivard, PhD; Christopher Levi, FRACP; Longting Lin, PhD; Xin Cheng, FRACP; Richard Aviv, FRACP; Neil J. Spratt,
More informationPredicting Infarction Within the Diffusion-Weighted Imaging Lesion Does the Mean Transit Time Have Added Value?
Predicting Infarction Within the Diffusion-Weighted Imaging Lesion Does the Mean Transit Time Have Added Value? Emmanuel Carrera, MD; P. Simon Jones, MSc; Josef A. Alawneh, MD; Irene Klærke Mikkelsen,
More informationRESEARCH ARTICLE. Ischemic Core Thresholds Change with Time to Reperfusion: A Case Control Study
RESEARCH ARTICLE Ischemic Core Thresholds Change with Time to Reperfusion: A Case Control Study Andrew Bivard, PhD, 1 Tim Kleinig, PhD, FRACP, 2 Ferdinand Miteff, FRACP, 1 Kenneth Butcher, FRACP, 3 Longting
More informationMost patients treated with intravenous tissue-type plasminogen
Negative Diffusion-Weighted Imaging After Intravenous Tissue-Type Plasminogen Activator is Rare and Unlikely to Indicate Averted Infarction Jason W. Freeman, MD; Marie Luby, PhD; José G. Merino, MD; Lawrence
More informationEarly and accurate detection of tissue at risk of infarction
The Role of Bolus Delay and Dispersion in Predictor Models for Stroke Lisa Willats, PhD; Alan Connelly, PhD; Soren Christensen, PhD; Geoffrey A. Donnan, MD, FRACP; Stephen M. Davis, MD, FRACP; Fernando
More informationUpdate on Early Acute Ischemic Stroke Interventions
Update on Early Acute Ischemic Stroke Interventions Diana Goodman MD Lead Neurohospitalist Maine Medical Center Assistant Professor of Neurology, Tufts University School of Medicine I have no disclosures
More informationFeasibility and Practicality of MR Imaging of Stroke in the Management of Hyperacute Cerebral Ischemia
AJNR Am J Neuroradiol 21:1184 1189, August 2000 Feasibility and Practicality of MR Imaging of Stroke in the Management of Hyperacute Cerebral Ischemia Peter D Schellinger, Olav Jansen, Jochen B Fiebach,
More informationEarly neurological stability predicts adverse outcome after acute ischemic stroke
Research Early neurological stability predicts adverse outcome after acute ischemic stroke International Journal of Stroke 2016, Vol. 11(8) 882 889! 2016 World Stroke Organization Reprints and permissions:
More informationTime to treatment is a critical factor in the outcome of
Treatment Time-Specific Number Needed to Treat Estimates for Tissue Plasminogen Activator Therapy in Acute Stroke Based on Shifts Over the Entire Range of the Modified Rankin Scale Maarten G. Lansberg,
More informationPerfusion Patterns of Ischemic Stroke on Computed Tomography Perfusion
Journal of Stroke 2013;15(3):164-173 http://dx.doi.org/10.5853/jos.2013.15.3.164 Review Perfusion Patterns of Ischemic Stroke on Computed Tomography Perfusion Longting Lin, a Andrew Bivard, b Mark W. Parsons
More informationThe most dreaded complication of thrombolytic therapy in
Impact of Baseline Tissue Status (Diffusion-Weighted Imaging Lesion) Versus Perfusion Status (Severity of Hypoperfusion) on Hemorrhagic Transformation Jong Hun Kim, MD; Oh Young Bang, MD, PhD; David S.
More informationDiffusion-weighted Magnetic Resonance Imaging in the Emergency Department
298 / = Abstract = Diffusion-weighted Magnetic Resonance Imaging in the Emergency Department Sung Pil Chung, M.D, Suk Woo Lee, M.D., Young Mo Yang, M.D., Young Rock Ha, M.D., Seung Whan Kim, M.D., and
More informationReliable Perfusion Maps in Stroke MRI Using Arterial Input Functions Derived From Distal Middle Cerebral Artery Branches
Reliable Perfusion Maps in Stroke MRI Using Arterial Input Functions Derived From Distal Middle Cerebral Artery Branches Martin Ebinger, MD; Peter Brunecker, MSc; Gerhard J. Jungehülsing, MD; Uwe Malzahn,
More informationThe Role of Neuroimaging in Acute Stroke. Bradley Molyneaux, HMS IV
The Role of Neuroimaging in Acute Stroke Bradley Molyneaux, HMS IV Patient CR 62 yo F w/ 2 wk h/o altered mental status Presents to ED w/ confusion following a fall 1 day prior New onset left facial droop
More informationAssessment of Tissue Viability Using Diffusion- and Perfusion-Weighted MRI in Hyperacute Stroke
Assessment of Tissue Viability Using Diffusion- and Perfusion-Weighted MRI in Hyperacute Stroke Won-Jin Moon, MD 1, 2 Dong Gyu Na, MD 1, 3 Jae Wook Ryoo, MD 1, 4 Hong Gee Roh, MD 1 Hong Sik Byun, MD 1
More informationThe mismatch between diffusion-weighted MRI (DWI) and
Interexaminer Difference in Infarct Volume Measurements on MRI A Source of Variance in Stroke Research Hakan Ay, MD; E. Murat Arsava, MD; Mark Vangel, PhD; Banu Oner, MD; Mingwang Zhu, MD; Ona Wu, PhD;
More informationSafety and Tolerability of Desmoteplase Within 3 to 9 Hours After Symptoms Onset in Japanese Patients With Ischemic Stroke
Safety and Tolerability of Desmoteplase Within 3 to 9 Hours After Symptoms Onset in Japanese Patients With Ischemic Stroke Etsuro Mori, MD, PhD; Kazuo Minematsu, MD, PhD; Jyoji Nakagawara, MD, PhD; Yasuhiro
More informationThe penumbra in acute stroke patients has been defined as brain tissue with loss of electric activity that retains the potential for recovery after ti
Note: This copy is for your personal non-commercial use only. To order presentation-ready copies for distribution to your colleagues or clients, contact us at www.rsna.org/rsnarights. Susanne Siemonsen
More informationAANS/CNS Response to CTAF Thrombectomy Brief Consideration of the IMS III, MR RESCUE and SYNTHESIS Thrombectomy Trials
AANS/CNS Response to CTAF Thrombectomy Brief Consideration of the IMS III, MR RESCUE and SYNTHESIS Thrombectomy Trials Prepared By Alexander A. Khalessi MD MS Director of Endovascular Neurosurgery Surgical
More informationMR RESCUE: Primary Results
MR RESCUE: Primary Results (Mechanical Retrieval and REcanalization of Stroke Clots Using Embolectomy) Funded by NIH-NINDS UCLA SPOTRIAS Grant: P50 NS044378 Clinical Trials.gov Number NCT00389467 FDA IDE
More informationRelative cerebral blood volume is associated with collateral status and infarct growth in stroke patients in SWIFT PRIME
Original Article Relative cerebral blood volume is associated with collateral status and infarct growth in stroke patients in SWIFT PRIME Journal of Cerebral Blood Flow & Metabolism 0(00) 1 9! Author(s)
More informationReport of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
SPECIAL ARTICLE Evidence-based guideline: The role of diffusion and perfusion MRI for the diagnosis of acute ischemic stroke Report of the Therapeutics and Technology Assessment Subcommittee of the American
More informationJournal of the Neurological Sciences
Journal of the Neurological Sciences 313 (2012) 142 146 Contents lists available at SciVerse ScienceDirect Journal of the Neurological Sciences journal homepage: www.elsevier.com/locate/jns Blood brain
More information